Use of cgrp antagonist compounds for treatment of psoriasis

Details Use of cgrp antagonist compounds for treatment of psoriasis Use of cgrp antagonist compounds for treatment of psoriasis

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 31/00 (2006.01) A61K 31/166 (2006.01) A61K 31/454 (2006.01) A61K 31/502 (2006.01) A61K 31/517 (2006.01) A61K 31/63 (2006.01) A61K 31/727 (2006.01) A61K 38/08 (2006.01) A61K 38/10 (2006.01) A61K 38/22 (2006.01) A61K 38/23 (2006.01) A61K 38/48 (2006.01) A61P 17/06 (2006.01) G01N 33/566 (2006.01)

Patent

CA 2495498

The invention provides methods and compositions for treating, preventing and/ or remedying psoriasis, based on compounds that have a calcitonin-related gene peptide (CGRP) antagonistic effect. Methods are also disclosed for identifying compounds with CGRP antagonist activity which thereby are suitable candidate compounds for treating psoriasis.

L'invention porte sur des méthodes et compositions de traitement et/ou prévention du psoriasis, basés sur des composés antagonistes du CGRP (peptide lié au gène de la calcitonine), et sur des méthodes d'identification de composés antagonistes du CGRP, et candidats éligibles pour le traitement du psoriasis.

Affiliated with

Also associated with

Rating

Use of cgrp antagonist compounds for treatment of psoriasis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of cgrp antagonist compounds for treatment of psoriasis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cgrp antagonist compounds for treatment of psoriasis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1357955